
![]()
Our History
Novartis was created in 1996 from the merger of the Swiss based life sciences companies, Ciba-Geigy and Sandoz. At the time, the merger was the largest in corporate history.
Since the merger in 1996, Novartis has transformed itself from a diverse group, including agribusiness, to a highly focused leading healthcare company.
The years since the merger have seen many strategic changes including the purchase of Hexal and Eon Labs, creating a world leader in generics under the brand name Sandoz, as well as the acquisition of Chiron Vaccines in 2006, taking Novartis to the forefront of vaccines and diagnostics.
Our UK Businesses

The Novartis business is divided into four divisions.
Research and Development

"We want to build the most competitive, most innovative research organisation with the most promising pipeline in industry to help people around the world".
Visit our R&D section for more about our pipeline and our R&D process